Phase 4 (PMR Pediatric Gad)
Research payments
$1,717,569
Through program year 2022, $1,717,569 in research payments was reported against Phase 4 (PMR Pediatric Gad), across 279 payments, paid by Allergan Inc..
- Paid by
- Allergan Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $49,646 | 35 |
| 2021 | Research | $1,667,924 | 244 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Adly Thebaud Sanford, FL Named on 58 payments
- James Knutson Kirkland, WA Named on 26 payments
- Writtika Roy Frisco, TX Named on 19 payments
- Judy Joseph Chicago, IL Named on 14 payments
- George Konis Little Rock, AR Named on 10 payments
- Rishi Kakar Tamarac, FL Named on 9 payments
- Shishuka Malhotra Canton, OH Named on 9 payments
- Bernardo Ng Imperial, CA Named on 8 payments
- Walter Faggett II Washington, DC Named on 7 payments
- Morteza Nadjafi Orlando, FL Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.